Senseonics (Nasdaq:SENS) announced new data from a real-world study demonstrating the sustained performance of its Eversense 365 CGM.

MiniMed (Nasdaq:MMED) announced today that it completed its previously announced initial public offering (IPO).

Dexcom (Nasdaq:DXCM) today announced its plans to share new data supporting its diabetes management technology at ATTD 2026.

Insulet (Nasdaq:PODD) today initiated a voluntary medical device correction for specific lots of Omnipod 5 insulin pump pods.

Abbott (NYSE:ABT) today announced results from a trial demonstrating better glucose outcomes for users of continuous glucose monitors (CGMs).

Afon Technology says that its Glucowear non-invasive continuous glucose monitor (CGM) demonstrated significant accuracy in its first trial.

Tandem Diabetes Care (Nasdaq:TNDM) announced today that it made its Mobi automated insulin delivery system available with ...

Glooko announced today that it agreed to integrate its diabetes management platform with the Roche Accu-Chek SmartGuide CGM.

Insulet (Nasdaq:PODD) shared new clinical evidence for its first fully closed-loop automated insulin delivery system for type 2 diabetes.

An Illinois judge sided with Abbott (NYSE:ABT) in a lawsuit related to alleged data sharing with its continuous glucose ...

Sequel Med Tech today announced the broad availability of its twiist automated insulin delivery system in the U.S.